|
Melanoma Therapeutics Foundation - About
Us
Mission
The incidence of melanoma is growing faster than any other
cancer in the U.S. and yet, of the hundreds of new drug candidates
that are currently in clinical testing, only a handful are
specifically targeted for melanoma. In addition, the FDA has
not approved a new drug for melanoma in over 15 years. It is
clear that there is a desperate need to accelerate the development
of new medicines to treat melanoma. [more details]
Interim Chair [more
details]
Melinda Ellis Evers
Executive Director [more
details]
Sally Park
Board of Directors
[more details]
Nils Behnke, Ph.D.
Wolf D. Busse, Ph.D.
Steve Ellis
Frank McCormick, Ph.D.,
F.R.S.
Consultants [more
details]
Wolf D. Busse,
Ph.D.
Ali Fattaey, Ph.D.
John W. Mahoney, J.D., M.A.
Scientific Advisory
Board [more details]
Frank McCormick, Ph.D.,
F.R.S.
Boris C. Bastian, M.D.
Martin McMahon, Ph.D.
Mohammad Kashani-Sabet, M.D.
Jeffrey Weber, M.D.,
Ph.D.
|
